In this regard, many clinical conditions and biomarkers such as age, hypertension, Interleukin-6 (IL-6) or D-dimer are associated with COVID-19 severity (2, 3) but the prediction of the clinical course and the pre-existing conditions that confer increased risk, remain a challenge for physicians. Here, IL6 is linked to hypertensive disorder.